Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
900
-1,990
-69% -$761K ﹤0.01% 1056
2026
Q1
$930K Buy
+2,890
New +$782K 0.01% 619
2025
Q3
– Sell
-9,785
Closed -$1.67M – 1583
2025
Q2
$1.67M Buy
9,785
+5,642
+136% +$813K 0.03% 411
2025
Q1
$484K Buy
+4,143
New +$559K 0.01% 827
2024
Q2
– Sell
-7,335
Closed -$684K – 2350
2024
Q1
$684K Buy
+7,335
New +$558K 0.02% 851
2023
Q3
– Sell
-4,632
Closed -$546K – 1961
2023
Q2
$546K Buy
4,632
+2,271
+96% +$222K 0.01% 789
2023
Q1
$223K Buy
+2,361
New +$224K 0.01% 1187
2021
Q3
– Sell
-4,936
Closed -$524K – 1503
2021
Q2
$524K Buy
4,936
+2,658
+117% +$289K 0.01% 813
2021
Q1
$213K Buy
+2,278
New +$195K 0.01% 946

Other funds holding MTZ

Centiva Capital's MTZ Position: Q2 2026 in Review

Centiva Capital reduced its MasTec (MTZ) stake by 69% in Q2 2026, selling an estimated $761K and leaving 900 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Centiva Capital first reported a position in MTZ in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.67M in Q2 2025. 912 funds tracked by Wall St. Rank hold MTZ as of Q2 2026.

  • Centiva Capital held 900 shares of MasTec worth $374K as of Q2 2026.
  • Centiva Capital sold 1,990 MasTec shares in Q2 2026, an estimated $761K.
  • MasTec made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1056 holding.
  • Centiva Capital first reported a position in MasTec in Q1 2021 and has held it in 9 quarters since.
  • Centiva Capital's MasTec position peaked at $1.67M in Q2 2025.
  • 912 funds tracked by Wall St. Rank held MasTec as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.